alt-803
Showing 1 - 22 of 22
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)
Withdrawn
- Triple Negative Breast Cancer (TNBC)
- Leucovorin
- +15 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)
Active, not recruiting
- Colorectal Cancer Metastatic
- mCRC
- Aldoxorubicin Hydrochloride
- +19 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)
Withdrawn
- Non Small Cell Lung Cancer
- Nab-paclitaxel
- +14 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Non Hodgkin Lymphoma Trial (biological, drug, radiation)
Withdrawn
- Non Hodgkin Lymphoma
- avelumab
- +13 more
- (no location specified)
Mar 17, 2021
Colorectal Cancer Trial (biological, drug, radiation)
Withdrawn
- Colorectal Cancer
- avelumab
- +21 more
- (no location specified)
Mar 17, 2021
Chordoma, Unresectable Malignant Tumor Trial in El Segundo (biological, drug, radiation)
Withdrawn
- Chordoma
- Unresectable Malignant Neoplasm
- Aldoxorubicin Hydrochloride
- +9 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 17, 2021
Merkel Cell Carcinoma Trial (biological, drug, radiation)
Withdrawn
- Merkel Cell Carcinoma
- Avelumab
- +14 more
- (no location specified)
Mar 17, 2021
Metastatic Pancreatic Cancer Trial in El Segundo (Gemcitabine, Nab-paclitaxel, Aldoxorubicin HCl)
Withdrawn
- Metastatic Pancreatic Cancer
- Gemcitabine
- +18 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 17, 2021
Triple Negative Breast Cancer Trial (biological, drug, radiation)
Withdrawn
- Triple Negative Breast Cancer
- avelumab
- +17 more
- (no location specified)
Mar 17, 2021
Melanoma Trial (biological, drug, radiation)
Withdrawn
- Melanoma
- Avelumab
- +17 more
- (no location specified)
Mar 17, 2021
Ovarian Cancer Trial (biological, drug, radiation)
Withdrawn
- Ovarian Cancer
- Avelumab
- +17 more
- (no location specified)
Mar 17, 2021
Urothelial Carcinoma Trial (biological, drug, radiation)
Withdrawn
- Urothelial Carcinoma
- avelumab
- +19 more
- (no location specified)
Mar 17, 2021
NSCLC Trial (biological, drug, radiation)
Withdrawn
- Non-small Cell Lung Cancer
- avelumab
- +21 more
- (no location specified)
Mar 17, 2021
Head and Neck Squamous Cell Carcinoma Trial (biological, drug, radiation)
Withdrawn
- Head and Neck Squamous Cell Carcinoma
- Avelumab
- +21 more
- (no location specified)
Mar 17, 2021
Pancreatic Cancer Trial in El Segundo (Cyclophosphamide, Oxaliplatin, Capecitabine)
Unknown status
- Pancreatic Cancer
- Cyclophosphamide
- +11 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Aug 10, 2020
Healthy Trial in Miami (ALT-803)
Completed
- Healthy
- ALT-803
-
Miami, FloridaQuotient Sciences
Aug 23, 2019
HIV, Stable ART Trial in Minneapolis (ALT-803)
Completed
- HIV
- Stable ART
- ALT-803
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 24, 2020
Multiple Myeloma Trial in Little Rock (drug, procedure, biological)
Withdrawn
- Multiple Myeloma
- Elotuzumab
- +4 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jul 8, 2020
Pancreatic Cancer Trial in El Segundo (biological, drug, procedure)
Unknown status
- Pancreatic Cancer
- ALT-803
- +13 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Aug 10, 2020
Pancreatic Cancer Trial in El Segundo (drug, biological, procedure)
Unknown status
- Pancreatic Cancer
- Aldoxorubicin HCl
- +18 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Jul 14, 2019
Pancreatic Cancer Trial in El Segundo (drug, biological, procedure)
Unknown status
- Pancreatic Cancer
- Aldoxorubicin HCl
- +14 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Jul 14, 2019